The Impact of Time-of-day Administration of EV/P on Objective Response Rate in Adults With Advanced Bladder Cancer
Clinical trial NCT07346053 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07346053
- Sponsor
- Guliz Ozgun
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2030-12-01
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.